Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,798 public trials 656 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, not recruiting

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

NCT06863961

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • The Center for Dermatology Clinical Research Fremont, California, United States
  • Dermatology Research Associate Los Angeles, California, United States
  • Olympian Clinical Research Tampa, Florida, United States
  • Hamilton Research, LLC Alpharetta, Georgia, United States
View all 60 locations
View Trial Details
Active, not recruiting

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

NCT03992417

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Investigational Site Number : 0320013 Pilar, Buenos Aires, Argentina
  • Investigational Site Number : 0320012 Rosario, Santa Fe Province, Argentina
  • Investigational Site Number : 0320011 Ciudad Autonoma Bs As, Argentina
  • Investigational Site Number : 0360002 Kogarah, New South Wales, Australia
View all 105 locations
View Trial Details
Active, not recruiting

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

NCT06940141

Conditions
Asthma, Asthma Acute, Bronchial Diseases, +7 more
Locations
  • Leland Stanford Junior University, Stanford Hospital Palo Alto, California, United States
  • Amicis Research Center Valencia, California, United States
  • Nemours Children's Hospital - DE Wilmington, Delaware, United States
  • Nemours Children's Health Jacksonville, Florida, United States
View all 58 locations
View Trial Details
Active, not recruiting

A 24-week rPMS Study in Real-world Setting for Enerzair

NCT05274425

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Daegu, Dalseo gu, South Korea
  • Novartis Investigative Site Wŏnju, Gangwon-do, South Korea
  • Novartis Investigative Site Bucheon-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
View all 21 locations
View Trial Details
Active, not recruiting

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

NCT05559359

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 85 locations
View Trial Details
Active, not recruiting

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

NCT05583227

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Los Angeles, California, United States
  • Research Site Aurora, Colorado, United States
View all 124 locations
View Trial Details

Related conditions